Combined Misoprostol and Cervical Balloon vs Misoprostol Alone for Induction on the First Day in Primiparas

Navigating NSAID safety in early pregnancy: Challenges in interpreting congenital malformation risk

This Perspective article by Yuen and Man discusses the challenges of interpreting research on NSAID safety during early pregnancy, particula

Study finds abortion bans restrict access to standard miscarriage care medication

A new national study finds that abortion bans, particularly those restricting abortion at or before 6 weeks of pregnancy, are negatively imp

First scientific study of menstruation in microgravity launched by Virgin Galactic and Operation Period

A non-profit called Operation Period, led by Gen-Z researchers, is launching the first-ever scientific study dedicated to researching menstr

Supreme Court Weighs Fifth Circuit Ruling Restricting Mail Delivery of Abortion Medication Mifepristone

The Supreme Court is considering whether to uphold a Fifth Circuit ruling that would prohibit abortion providers from mailing mifepristone,

FDA Launches Safety Review of Abortion Drug Mifepristone; Trans Youth Sue to Shield Health Records

The article reports on three major abortion-related developments: (1) The FDA has initiated a safety review of mifepristone, an abortion med

<![CDATA[Study Links Several Progestogen Contraceptives to Rare Meningioma Risk, Reinforcing Individualized Patient Counseling]]>